FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioTelemetry's Free Cash Flow for the
three
months ended in Sep. 2020 was $11.1 Mil. BioTelemetry's Revenue for the
three
months ended in Sep. 2020 was $114.7 Mil. Therefore, BioTelemetry's FCF Margin % for the quarter that ended in Sep. 2020 was 9.70%.
The historical rank and industry rank for BioTelemetry's FCF Margin % or its related term are showing as below:
BEAT'
s FCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 16.29
Current: 16.29
During the past 13 years, the highest FCF Margin % of BioTelemetry was 16.29%. The lowest was 0.00%. And the median was 0.00%.
BEAT's FCF Margin % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -10.51
vs BEAT: 16.29
BioTelemetry FCF Margin % Historical Data
The historical data trend for BioTelemetry's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioTelemetry's FCF Margin %
For the Diagnostics & Research subindustry, BioTelemetry's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioTelemetry's FCF Margin % Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BioTelemetry's FCF Margin % distribution charts can be found below:
* The bar in red indicates where BioTelemetry's FCF Margin % falls into.
BioTelemetry FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
BioTelemetry's FCF Margin for the fiscal year that ended in Dec. 2019 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioTelemetry FCF Margin % Related Terms
Thank you for viewing the detailed overview of BioTelemetry's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BEAT has been successfully added to your 